Literature DB >> 3462701

Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes.

H L Sive, R G Roeder.   

Abstract

We have examined the interaction of factors in HeLa cell nuclear extracts with a human histone H2B gene (H2B) promoter. Protein-DNA mobility-shift and DNase I protection assays detected a factor(s) binding to a 15-base-pair consensus element that is essential for efficient H2B transcription in vitro. Part of this consensus sequence is the octanucleotide ATTTGCAT, which is apparently a functional component of several non-histone genes. A subset of these genes, including a human U2 small nuclear RNA (snRNA) gene promoter, a mouse immunoglobulin heavy chain enhancer, and a mouse light chain promoter, were shown to interact with the H2B consensus sequence-binding factor(s). These results suggest that a common factor or closely related factors may contribute to the regulation of these and other genes that share the octanucleotide sequence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462701      PMCID: PMC386507          DOI: 10.1073/pnas.83.17.6382

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  The primary structure and expression of four cloned human histone genes.

Authors:  R Zhong; R G Roeder; N Heintz
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

3.  Two regulatory elements for immunoglobulin kappa light chain gene expression.

Authors:  Y Bergman; D Rice; R Grosschedl; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence.

Authors:  T G Parslow; D L Blair; W J Murphy; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Structure of two unlinked Drosophila melanogaster glyceraldehyde-3-phosphate dehydrogenase genes.

Authors:  J Y Tso; X H Sun; R Wu
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

7.  Orientation-dependent transcriptional activator upstream of a human U2 snRNA gene.

Authors:  M Ares; M Mangin; A M Weiner
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

8.  Genomic organization and nucleotide sequence of two distinct histone gene clusters from Xenopus laevis. Identification of novel conserved upstream sequence elements.

Authors:  M Perry; G H Thomsen; R G Roeder
Journal:  J Mol Biol       Date:  1985-10-05       Impact factor: 5.469

9.  A general upstream binding factor for genes of the yeast translational apparatus.

Authors:  J Huet; P Cottrelle; M Cool; M L Vignais; D Thiele; C Marck; J M Buhler; A Sentenac; P Fromageot
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

10.  Human U2 and U1 RNA genes use similar transcription signals.

Authors:  G Westin; E Lund; J T Murphy; U Pettersson; J E Dahlberg
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  100 in total

1.  Combination of a zinc finger and homeodomain required for protein-interaction.

Authors:  Gregory E Smith; Douglas S Darling
Journal:  Mol Biol Rep       Date:  2003-12       Impact factor: 2.316

2.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

3.  A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

Authors:  G L Bream; P Vaillancourt; M R Botchan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity.

Authors:  C L Dent; K A Lillycrop; J K Estridge; N S Thomas; D S Latchman
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Xenopus laevis Oct-1 does not bind to certain histone H2B gene promoter octamer motifs for which a novel octamer-binding factor has high affinity.

Authors:  D P Smith; R W Old
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

7.  Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.

Authors:  T A Libermann; M Lenardo; D Baltimore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.

Authors:  B Nelsen; T Kadesch; R Sen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.

Authors:  J P Cogswell; P V Basta; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.